BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12933340)

  • 1. Improvement in diastolic intraventricular pressure gradients in patients with HOCM after ethanol septal reduction.
    Rovner A; Smith R; Greenberg NL; Tuzcu EM; Smedira N; Lever HM; Thomas JD; Garcia MJ
    Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2492-9. PubMed ID: 12933340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive assessment of left ventricular relaxation property using color M-mode-derived intraventricular pressure gradients in cats.
    Matsuura K; Bach MBT; Takahashi K; Willesen JL; Koch J; Tanaka R
    J Vet Cardiol; 2022 Jun; 41():236-248. PubMed ID: 35653883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.
    Flores-Ramirez R; Lakkis NM; Middleton KJ; Killip D; Spencer WH; Nagueh SF
    J Am Coll Cardiol; 2001 Jan; 37(1):208-14. PubMed ID: 11153740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy.
    Sitges M; Shiota T; Lever HM; Qin JX; Bauer F; Drinko JK; Agler DA; Martin MG; Greenberg NL; Smedira NG; Lytle BW; Tuzcu EM; Garcia MJ; Thomas JD
    Am J Cardiol; 2003 Apr; 91(7):817-21. PubMed ID: 12667567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of diastolic intraventricular pressure gradients by Doppler M-mode echocardiography.
    Greenberg NL; Vandervoort PM; Firstenberg MS; Garcia MJ; Thomas JD
    Am J Physiol Heart Circ Physiol; 2001 Jun; 280(6):H2507-15. PubMed ID: 11356605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of diastolic intraventricular pressure gradients and aerobic capacity in patients with diastolic heart failure.
    Rovner A; Greenberg NL; Thomas JD; Garcia MJ
    Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2081-8. PubMed ID: 15937093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of suction force during early diastole from the left atrium to the left ventricle in infants, children, and adolescents.
    Takahashi K; Nii M; Takigiku K; Toyono M; Iwashima S; Inoue N; Tanaka N; Matsui K; Shigemitsu S; Yamada M; Kobayashi M; Yazaki K; Itatani K; Shimizu T
    Heart Vessels; 2019 Feb; 34(2):296-306. PubMed ID: 30155660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Spencer WH
    J Am Coll Cardiol; 1999 Oct; 34(4):1123-8. PubMed ID: 10520801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
    Qin JX; Shiota T; Lever HM; Kapadia SR; Sitges M; Rubin DN; Bauer F; Greenberg NL; Agler DA; Drinko JK; Martin M; Tuzcu EM; Smedira NG; Lytle B; Thomas JD
    J Am Coll Cardiol; 2001 Dec; 38(7):1994-2000. PubMed ID: 11738306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy.
    Menon SC; Ackerman MJ; Ommen SR; Cabalka AK; Hagler DJ; O'Leary PW; Dearani JA; Cetta F; Eidem BW
    J Am Soc Echocardiogr; 2008 Jun; 21(6):684-8. PubMed ID: 18187287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
    van Ramshorst J; Mollema SA; Delgado V; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
    Am J Cardiol; 2009 Jun; 103(11):1592-7. PubMed ID: 19463521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Septal Reduction on Left Atrial Size and Diastole in Hypertrophic Cardiomyopathy.
    Finocchiaro G; Haddad F; Kobayashi Y; Lee D; Pavlovic A; Schnittger I; Sinagra G; Magavern E; Myers J; Froelicher V; Knowles JW; Ashley E
    Echocardiography; 2016 May; 33(5):686-94. PubMed ID: 26926154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insight into the intraventricular pressure gradient as a sensitive indicator of diastolic cardiac dysfunction in patients with childhood cancer after anthracycline therapy.
    Shigemitsu S; Takahashi K; Yazaki K; Kobayashi M; Yamada M; Akimoto K; Tamaichi H; Fujimura J; Saito M; Nii M; Itatani K; Shimizu T
    Heart Vessels; 2019 Jun; 34(6):992-1001. PubMed ID: 30673819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cibenzoline, a class ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy.
    Kondo I; Mizushige K; Nozaki S; Iwado Y; Masugata H; Kohno M; Matsuo H
    Cardiovasc Drugs Ther; 2001 Sep; 15(5):459-65. PubMed ID: 11855665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic left ventricular outflow and its mechanism in hypertrophic obstructive cardiomyopathy.
    Conklin HM; Huang X; Davies CH; Sahn DJ; Shively BK
    J Am Soc Echocardiogr; 2004 Apr; 17(4):375-83. PubMed ID: 15044873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Doppler echocardiographic evaluation of left ventricular diastolic function in patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation in acute and long-term follow up].
    Wojtarowicz A; Kornacewicz-Jach Z; Kaźmierczak J; Szamlewski P; Gil R; Lewandowski M
    Pol Merkur Lekarski; 2002 Jul; 13(73):25-8. PubMed ID: 12362500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Ommen SR; Lakkis NM; Killip D; Zoghbi WA; Schaff HV; Danielson GK; Quiñones MA; Tajik AJ; Spencer WH
    J Am Coll Cardiol; 2001 Nov; 38(6):1701-6. PubMed ID: 11704383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of inter-system variability of systolic and diastolic intraventricular pressure gradients derived from color Doppler M-mode echocardiography.
    Hodzic A; Bonnefous O; Langet H; Hamiche W; Chaufourier L; Tournoux F; Milliez P; Normand H; Saloux E
    Sci Rep; 2020 Apr; 10(1):7180. PubMed ID: 32346030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
    Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
    Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.
    Faber L; Welge D; Fassbender D; Schmidt HK; Horstkotte D; Seggewiss H
    Clin Res Cardiol; 2007 Dec; 96(12):864-73. PubMed ID: 17891518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.